ARCHIVES

Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Phase II Trial Tests Vaccine Plus Hormone Therapy For Recurrent Prostate Cancer

August 26, 2005

Cancer Planners Revise Some Project Areas, Drop Some, Add New Ones

February 8, 1974

R. Lee Clark, 87, M.D. Anderson Mastermind, dies

May 13, 1994

Text of Peer Review Of Medenica’s Treatment Of Breast Cancer Patient

April 30, 1993

Cancer Program Critics Called “Irresponsible,” Demagogues”

March 21, 1975

In Phase II Study, NKTR-102 Shows Objective Response

January 28, 2011